Lifeward enters $525K secured note with Oramed at 24% interest, expandable by $975K

Lifeward Ltd.

Initial principal $525,000; mutual consent can increase by up to $975,000 for total up to $1.5M.
Interest at 24% per annum; matures earlier of August 12, 2026 or failure to obtain shareholder approval.
Note secured by lien on company's cash; proceeds applied ratably with existing $3M secured note.
Customary covenants limit additional debt, liens, asset sales, and affiliate transactions.
Events of default include non-payment, covenant breach, insolvency, or material adverse effect.

item 1.01item 2.03

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.